Sebastien A. Levesque
Sherbrooke, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Analysing long-read CRISPR experiments with CRISPRLungo.
Journal: Nature biomedical engineering
Published: November 24, 2025
Autophagy disruption primes CAR-T cell metabolism for sustained rejection of ovarian tumors.
Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025
In cellulo DNA assembly for targeted genomic integration and rearrangement in human cells.
Journal: bioRxiv : the preprint server for biology
Published: July 16, 2025
Non-genotoxic transplantation and in vivo selection through epitope editing.
Journal: Nature
Published: June 30, 2025
CRISPR-based therapeutic genome editing for inherited blood disorders.
Journal: Nature reviews. Drug discovery
Published: June 03, 2025
PMS2 c.2117del (p.Lys706Serfs*19) is the Most Frequent Cancer-Associated Founder Pathogenic Variant in the French-Canadian Population of Quebec, Canada.
Journal: Clinical genetics
Published: March 22, 2025
Enhancing prime editing in hematopoietic stem and progenitor cells by modulating nucleotide metabolism.
Journal: Nature biotechnology
Published: October 16, 2023
Gene editing without ex vivo culture evades genotoxicity in human hematopoietic stem cells.
Journal: Cell stem cell
Published: June 12, 2023
Gene correction for sickle cell disease hits its prime.
Journal: Nature biomedical engineering
Published: May 19, 2023
Dairy phages escape CRISPR defence of Streptococcus thermophilus via the anti-CRISPR AcrIIA3.
Journal: International journal of food microbiology
Published: May 13, 2023
Improving prime editing with an endogenous small RNA-binding protein.
Journal: Nature
Published: April 25, 2023
"Acquired" Brugada syndrome in a cardiac allograft.
Journal: Pediatric transplantation
Published: February 07, 2022
Last Updated: 09/26/2026